Chemotherapy-induced alopecia: comprendre, anticiper, accompagner.

“Am I going to lose my hair? » This question, asked by many patients as soon as treatment is announced, may seem secondary given the seriousness of an oncological diagnosis. She is not. Behind it lies another, deeper one, which concerns the place of each person in the eyes of others and the continuity of their identity.

Most of the side effects of chemotherapy – fatigue, nausea, reduced immunity – remain invisible to those around you. Alopecia is immediately visible. She transforms an intimate ordeal into a public reality and reports the illness to anyone she meets in the street, at work or in the family. This is what makes it, for many, the most difficult side effect to deal with psychologically, regardless of its medical seriousness.

La dimension sociale et identitaire

Hair contributes to self-image, feelings of femininity or masculinity, and social recognition. Their sudden loss can cause a feeling of dispossession, difficulty recognizing oneself in the mirror, and social withdrawal. The experience varies greatly from one person to another, but the impact on self-esteem and quality of life is documented as real and deserves to be taken seriously, never minimized.

The issue of adherence to treatment

In some patients, the prospect of losing their hair can weigh on acceptance of treatment, or even lead, in rare cases, to hesitation about the proposed protocol. Recognizing this issue and offering hair support as soon as the announcement is made contributes to a better care experience and, indirectly, to better therapeutic adherence. This is one of the reasons why hair support finds its legitimate place in oncology supportive care.

To understand alopecia, you need to understand how chemotherapy works. Cytotoxic agents were designed to destroy rapidly dividing cells — the primary characteristic of cancer cells. But this action is not perfectly selective: other tissues of the body are also renewed very quickly and suffer collateral damage. The digestive mucosa, bone marrow and hair follicle are among the most exposed.

The hair follicle, an organ with intense renewal

The hair follicle is a real little biological factory. At its base, the matrix contains some of the most active cells in the entire body: they constantly divide to produce the hair shaft, at a rate that makes them a prime target for treatments. It is precisely this intensity of renewal which explains the sensitivity of hair to chemotherapy.

Anagen, catagen, telogen: the hair cycle

Each hair follows a three-phase life cycle. The anagen phase is the active growth phase, during which hair grows — it lasts several years and affects the vast majority of hair at any given time. The catagen phase is a short transition. The telogen phase is a period of rest which ends with the natural loss of hair, which is replaced by a new one.

Chemotherapy mainly affects hair in the anagen phase, that is to say, in full growth. As they represent the majority of the hair, the loss can be rapid and massive: this is called anagen effluvium. This is what distinguishes chemotherapy alopecia from other, more progressive forms of hair loss.

The fall does not occur from the first infusion. It most often begins two to three weeks after the first treatment, until the effect on the growing follicles is visibly visible. It can be progressive, in handfuls when brushing or on the pillow, or faster and more brutal depending on the molecules and doses.

The magnitude varies considerably between protocols. Some treatments cause almost total alopecia, others partial loss, still others minimal or no hair loss. Only the healthcare team can indicate what is expected in a specific situation, depending on the medications used.

Une chute qui ne concerne pas que les cheveux

Because chemotherapy acts on all follicles, loss can affect eyelashes, eyebrows, facial and body hair. The loss of eyelashes and eyebrows has a particular impact: it modifies facial expression and its protective role, and it is sometimes experienced as even more destabilizing than hair loss.

Not all chemotherapies are equal for hair. The risk of alopecia depends on the nature of the molecules, but also on their dose, their association and the rhythm of the treatments. Understanding this gradation helps you prepare realistically, without dramatizing or underestimating.

The table below gives general benchmarks by major treatment families. These are indicative orders of magnitude: only the healthcare team can specify the real risk of a given protocol, because the combinations of molecules significantly modify the result.

With the same protocol, two people do not always experience the same fall. Several factors come into play and explain this variability, which it is useful to know so as not to hastily compare your experience to that of others.

• Dose and frequency. High or close doses increase the effect on the follicles.
• The association of molecules. Several combined agents often increase the risk compared to a single molecule.
• Route of administration. Intravenous infusions at high concentrations are generally more alopecia-inducing.
• Les mesures de protection. The cooling helmet can reduce the fall for certain protocols.
• Le terrain individuel. The initial condition of the scalp and each person's own sensitivity play a role, which is still imperfectly understood.

This variability explains why no serious professional can promise a precise individual result, whether on loss or regrowth. Caution in speaking is part of honest support, faithful to the approach of the RENASCOR Laboratory.

Several beliefs circulate and sometimes add unnecessary anxiety. Here are some of them, compared to what we know.

“If I lose my hair, it’s because the treatment is more aggressive. »

Fake. Alopecia reflects the sensitivity of the follicle to certain molecules, not the overall intensity or effectiveness of the treatment. Very effective protocols cause few drops, and vice versa.

“Cutting or shaving my hair slows down its loss. »

The cut does not act on the mechanism of the fall, which occurs at the root. On the other hand, shortening before the fall can make the transition psychologically less brutal and easier to manage on a daily basis.

“The regrowth will necessarily be identical to before. »

Not always. Regrowth is most often satisfactory, but a temporary change in texture or color is common, and permanently incomplete regrowth (PACIA) is possible in certain cases.

“There is nothing to do except wait. »

This is precisely the belief that hair reconstruction challenges: acting on the biological field of the follicle aims to improve the conditions for regrowth, instead of just waiting or camouflaging.

Anticipating does not eliminate the fall, but transforms the way we live it. To prepare is to regain some control over a process undergone. Supportive care — including hair support — is precisely aimed at preserving quality of life during and after treatments.

Pre- and On-treatment Biopsies

• Find out from the healthcare team what is expected for their protocol.
• Envisager une coupe plus courte en amont, pour rendre la transition moins brutale.
• Discover covering solutions (scarves, hair prostheses) without rushing.
• Take care of your scalp gently, to preserve a favorable environment for regrowth.

After treatment: prepare and support regrowth

The end of the treatments opens the regrowth phase. This is the moment when hair reconstruction takes on its full meaning: rather than just waiting or hiding, it is about acting on the biological conditions of regrowth. This approach, developed by the RENASCOR Laboratory, is based on a simple principle — we reconstruct before stimulating, without minoxidil or hormonal active ingredients.

The role of the hair support professional

Socio-hairdressers, socio-beauticians, trichologists and trained pharmacists work in addition to the healthcare team, never in its place. Their role is to listen, guide and support, while respecting a clear ethical framework. Socio-hairdressing in oncology is the branch dedicated to this support.

Placing the fall and the regrowth in an overall chronology helps to plan ahead. The benchmarks below are indicative and vary depending on people and protocols.

• Before the first treatment. Ideal time to get information, consider a haircut and discover supporting solutions, without rushing.
• Weeks 2 to 3 after the first treatment. Usual onset of fall, gradual or rapid depending on the treatments.
• Pendant le traitement. The fall continues; Gentle scalp care aims to preserve favorable conditions.
• Fin du traitement. The follicles gradually resume their activity; this is the starting point for regrowth and the moment when hair reconstruction takes on its meaning.
• Next weeks to months. Appearance of a down, then the first lengths, then densification. Texture and color may be temporarily changed.
• Several months later. Stabilization. In the event of long-term incomplete regrowth, specialist advice is recommended to evaluate a possible PACIA.

Alopecia does not only affect the sick person: it also questions those around them, who are often helpless in the face of this visible sign of the disease. A few cues help support without awkwardness.

• Recognize without dramatizing. Name the ordeal without reducing it to a detail, but without making it the center of all conversations either.
• Proposer sans imposer. Suggest concrete help — help you choose a scarf, make an appointment with a professional — leaving the decision up to the person.
• Respecter les choix. Some assume bareheaded, others prefer to cover: there is no single good way to experience this stage.
• Penser aux enfants. Explaining in simple words that this is a treatment effect, temporary in most cases, helps to ease their concerns.